Mark Becker
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in ⓘ
-
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 4
- Tuberculosis Research and Epidemiology 1
- Virology 8
- HIV Research and Treatment 8
- Co-authors
- Carla Pettinelli (1 shared paper)Paul A. Volberding (1 shared paper)Robert M. Grant (1 shared paper)Charles van der Horst (1 shared paper)Laura Smeaton (1 shared paper)Stefano Vella (1 shared paper)Steven G. Deeks (1 shared paper)Michael P. Dubé (1 shared paper)
- Journals
- Antiviral Therapy (2 papers)Journal of Antimicrobial Chemotherapy (1 paper)Cornea (1 paper)The Journal of Clinical Pharmacology (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Mark Becker
10 papers receiving 481 citations
Peers
Comparison fields: 5 of 44
- Virology 399
- Infectious Diseases 453
- Emergency Medicine 87
- Hepatology 18
- Epidemiology 53
Countries citing papers authored by Mark Becker
This map shows the geographic impact of Mark Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Becker more than expected).
Fields of papers citing papers by Mark Becker
This network shows the impact of papers produced by Mark Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Becker. The network helps show where Mark Becker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Becker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 272 | |
| 2 | 1999 | 138 | |
| 3 | 2001 | 30 | |
| 4 | 2003 | 22 | |
| 5 | 2001 | 13 | |
| 6 | 1989 | 12 | |
| 7 | 2006 | 10 | |
| 8 | 2007 | 10 | |
| 9 | 2005 | 9 | |
| 10 | 2007 | 4 |
About Mark Becker
Mark Becker is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Pharmacology, having authored 10 papers that have together received 520 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (4 papers), HIV-related health complications and treatments (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper), Antibiotic Resistance in Bacteria (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Virology (399 citations), Infectious Diseases (453 citations), Emergency Medicine (87 citations), Hepatology (18 citations) and Epidemiology (53 citations). Mark Becker has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Carla Pettinelli, Paul A. Volberding, Robert M. Grant, Charles van der Horst, Laura Smeaton, Stefano Vella, Steven G. Deeks, Michael P. Dubé, Sally Snyder and Christos J. Petropoulos. Their work appears in journals such as Antiviral Therapy, Journal of Antimicrobial Chemotherapy, Cornea, The Journal of Clinical Pharmacology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.